Skip to main content

Gilead signals beyond the news: 40+ signals from 6 sources

The latest Gilead signal on this page is from Oct 27, 2026 (Patents): "Gilead Sciences, Inc.'s patent output is slowing: 35 grants in the past year, 0 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (9) and Employee growth (7).

Public (GILD)Biotechnology Research10,000+ employeesgilead.comLinkedIn

Get Gilead's live signals in Claude or ChatGPT, or by API

AskWhat changed at Gilead this week? Use Autobound signals for gilead.com.
Signals
40+
Sources
6
Last 90 days
23
Latest
Oct 27, 2026

Source: Autobound Signal API · 68 signals tracked for Gilead · updated

Other signals · latest 10

Latest Gilead signals by source

40+ signals for Gilead across 6 sources.

  1. Patents · Patent pace

    Gilead Sciences, Inc.'s patent output is slowing: 35 grants in the past year, 0 in the past 30 days.

    Over the past year Gilead Sciences, Inc. received 35 US patent grants; the recent pace (3 in 90 days) is slowing versus its trailing baseline.

    Grants, 12 months
    35
    Grants, 90 days
    3
    Grants, 30 days
    0
    Pace
    Decelerating

    Google Patents

  2. Glassdoor · Poor work life balance

    Employees report long hours and overwhelming workload due to lean staffing

    Two reviewers mention long hours and high-speed work, with one stating the workload is overwhelming because the company is very lean. Another senior director notes long hours.

    Overall rating
    3.6 of 5
    CEO approval
    74%
    Reviews read
    8
    Review window
    Sep 11, 2026 to Oct 9, 2026

    Glassdoor

  3. Glassdoor · High culture praise

    Positive culture and great science are praised despite some challenges

    A Sr. Director highlights an inclusive, patient-centered culture and great science, while a Senior Manager also mentions great science and good team dynamics.

    Overall rating
    3.6 of 5
    CEO approval
    74%
    Reviews read
    8
    Review window
    Sep 11, 2026 to Oct 9, 2026

    Glassdoor

  4. Reddit · Customer feedback

    A Goldman Sachs analyst report highlighted that Gilead's Hepatitis C cure is projected to generate less than $4 billion in annual revenue, down from a cumulative total of $73 billion, questioning...

    Post: "“Is curing patients a sustainable business model?” Goldman Sachs analysts ask. Analyst report notes that Gilead’s hep C cure will make less than $4 billion..."

    Subreddit
    r/biotech
    Upvotes
    300
    Comments
    59
    Sentiment
    Neutral

    r/biotech

  5. Reddit · Product launch

    The U.S.

    Post: "GILD | U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex..."

    Subreddit
    r/StockTitan
    Upvotes
    2
    Comments
    0
    Sentiment
    Positive

    r/StockTitan

  6. Website changes · Community engagement

    Gilead added a prominent collaboration with National Geographic CreativeWorks to highlight its global-health and access mission.

    Added text: “BRIDGE TO BREAKTHROUGH Gilead has collaborated with National Geographic CreativeWorks to tell the story of how scientific innovation leads to real-world impact,” with a link to “Global Health and Access.”

    Page
    /

    gilead.com

  7. Website changes · Partnership announcement

    Gilead added a dedicated employment-verification process for U.S. employees, directing users to Experian Verify or contacting customer service support.

    Added text: “Employment Verification To request a verification of employment for U.S. Gilead employees, visit www.experianverify.com or contact Experian Verify customer service support at 404-382-5400.”

    Page
    /contact-us

    gilead.com

  8. Patents · Patent counsel

    Gilead Sciences, Inc. uses McAndrews Held & Malloy, Ltd. as outside IP counsel.

    McAndrews Held & Malloy, Ltd. is the attorney of record on Gilead Sciences, Inc.'s recent US patent work, including a grant in 2026-08.

    Law firm
    McAndrews Held & Malloy, Ltd.
    Law firm domain
    mcandrews-ip.com
    Matter date
    Aug 11, 2026

    Google Patents

  9. Podcasts · Tech adoption

    AUTM on the Air discusses Gilead: tech adoption

    "In the case of Gilead, actually Remdesivir, or the treatment of COVID-19, is one of the medications that use the Captisol technology."

    Podcast
    AUTM on the Air
    Episode
    Advancing Biopharma Innovation with Ruben Flores-Saaib
    Speaker
    Ruben Flores-Saaib
    Speaker role
    Counterparty

    AUTM on the Air

  10. Employee growth · Headcount change

    Slow growth (0% YoY) for a enterprise company with 14,493 employees.

    Company's 0% headcount growth represents slow expansion for a enterprise company. This adds approximately 0 employees lost over the past year.

    Total headcount
    14,493
    Company growth, 1 year
    0%
    Median tenure
    5 years

Showing 10 of 40+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Gilead with the Signal API

One POST /v1/companies/enrich call with gilead.com returns Gilead signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "gilead.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Gilead other signals

What signals does Autobound track for Gilead besides news and filings?
This page lists 40+ signals for Gilead from 6 sources: Glassdoor (15+), Website changes (9), Employee growth (7), Patents (4), Reddit (3) and Podcasts (2). Every row is dated, and most link to the post, review or record.
What are people saying about Gilead online?
The newest posts on this page: Sep 23, 2026, Reddit (r/biotech): A Goldman Sachs analyst report highlighted that Gilead's Hepatitis C cure is projected to generate less than $4 billion in annual revenue, down from a cumulative total of $73 billion, questioning... Aug 27, 2026, Reddit (r/StockTitan): The U.S. Aug 27, 2026, Reddit (r/NBCauto): The FDA approved a new daily HIV pill from Gilead designed to simplify treatment for certain patients.
What do employees say about working at Gilead?
The newest Glassdoor theme on this page, dated Oct 9, 2026: Employees report long hours and overwhelming workload due to lean staffing. The overall rating in that row is 3.6 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Gilead been granted patents recently?
Yes. The newest grant on this page: Jul 14, 2026, Patents (Google Patents): Gilead Sciences was granted a patent for tenofovir and emtricitabine formulations.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →